Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Phase II Trial of Single Fraction Real-time High-Dose-Rate (19-HDR) Brachytherapy in Patients With Low and Intermediate Risk Prostate Cancer

NCT02342054 is registered in ClinicalTrials.gov with Hospital de Cruces as lead sponsor.

NCT NCT02342054
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02342054 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Phase II Trial of Single Fraction Real-time High-Dose-Rate (19-HDR) Brachytherapy in Patients With Low and Intermediate Risk Prostate Cancer
Lead sponsor
Hospital de Cruces
Phase
Phase 2
Overall status
Unknown status
Start date
October 31, 2014
Completion date
December 31, 2017
Enrollment
49 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer